Form D · Other Health Care
Enumera Molecular, Inc.
Ann Arbor, MI · CIK 0001929085
Offering snapshot reported Jul 31, 2026 · SEC filing
- Reported sold
- $12.3M Offering amount: $17.4M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2026 | Initial | $12,325,344 | No comparison | 12 | SEC filing |
| Aug 22, 2022 | Amendment | $18,720,000 | $2,720,000vs May 17, 2022 | 5 | SEC filing |
| May 17, 2022 | Initial | $16,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592826
Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.
Source: Form D, filed Jul 31, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sundaresh Brahmasandra | Director |
| Matthew Cooper | Director, Executive |
| Elaine Heron | Director |
| Dan Kidle | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
600 S. Wagner Rd. Bldg. 1
Ann Arbor, MI, 48103
Ann Arbor, MI, 48103